Observational studyBMC nephrology2026
Impact of CKD and COPD co-existence on mortality, vascular dementia, and Alzheimer's dementia; a comparative cohort study.
Observational study in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic kidney disease (CKD) and chronic obstructive pulmonary disease (COPD) are common conditions associated with increased risks of mortality and cognitive impairment. However, the association between COPD and dementia outcomes in patients with CKD remains incompletely understood.
methodsWe conducted a retrospective observational cohort study using the TriNetX Global Collaborative Network, including patients aged 18-80 years with CKD stages 3-5, excluding those with prior dialysis, transplantation, dementia, or mild cognitive impairment before cohort entry. Two cohorts were identified: CKD with COPD, defined using classical ICD-10 COPD codes (J41-J44), and CKD without COPD. A secondary sensitivity analysis used a broader respiratory disease definition including asthma, bronchiectasis, and other chronic respiratory conditions. Cohorts were propensity score matched (1:1) for demographic characteristics, comorbidities, smoking exposure, and laboratory parameters. Outcomes included all-cause mortality, non-Alzheimer's dementia, and Alzheimer's disease, assessed over a maximum follow-up of 5 years using Kaplan-Meier and Cox proportional hazards analyses.
resultsTwo cohorts were identified: CKD with COPD (n = 270 566) and CKD without COPD (n = 821 399). After propensity score matching, 234 317 patients remained in each cohort. CKD with COPD was associated with a higher observed risk of mortality compared with CKD alone (18.5% vs. 14.5%; HR 1.17; 95% CI 1.16-1.19; p < 0.001). The composite outcome of non-Alzheimer's dementia was also more frequent in the CKD with COPD cohort (4.6% vs. 3.9%; HR 1.07; 95% CI 1.04-1.10; p < 0.001). No significant association was observed for vascular dementia alone or mild cognitive impairment alone. Alzheimer's disease incidence was low in both cohorts, and lower observed hazards were identified in the COPD cohort (HR 0.85; 95% CI 0.80-0.91; p = 0.002), although these findings should be interpreted cautiously given the relatively short follow-up and higher competing mortality in the COPD cohort.
conclusionsAmong patients with CKD, coexisting COPD was associated with higher observed risks of mortality and non-Alzheimer's dementia during follow-up. Further longitudinal studies with longer follow-up and competing-risk methodology are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.